2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$4.73-$0.18 (-3.74%)
Price as of Oct 22, 2026 7:30 PM EDT- $714.6MMarket Cap
- 197.88%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$4.73-$0.18 (-3.74%)
OABI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.92 | ||
Change | -$0.04 (-0.91%) | ||
Open | $4.96 | ||
High | $5.13 | ||
Low | $4.80 | ||
Previous Close | $4.96 | ||
Volume | 3,176,487 | ||
30-Day Average Volume | 1,340,720 | ||
1-Week Change | 8.02% | ||
1-Month Change | 7.31% | ||
1-Year Change | 197.88% | ||
3-Year Change | 1.34% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 145.4M | ||
Total Assets | $290.3M | ||
Market Cap | $714.6M | ||
Enterprise Value | $690.3M | ||
Period: QTR TTM FY | |||
Revenue | $9.5M | ||
Net Income | -$5.9M | ||
Free Cash Flow | $2.6M | ||
EBIT | -$6.2M | ||
EBITDA | -$3.2M | ||
Net Working Capital | $52.3M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -219 | ||
Enterprise Value/Revenue | 73 | ||
P/B | 3 | ||
P/E | -98 | ||
PEG | -6 | ||
Price/Free Cash Flow | 278 | ||
Price/Operating Cash Flow | 267 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue